A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation

NCT04627142 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Metastatic Colorectal Cancer (CRC)

Interventions

DRUG: BI 1701963
DRUG: Camptosar®

Sponsor

Boehringer Ingelheim